Cingulate (NASDAQ: CING) awards 20,000 stock options to board director
Rhea-AI Filing Summary
Cingulate Inc. director Thomas Jeffrey Hargroves received a grant of 20,000 stock options for Common Stock at an exercise price of $4.43 per share. The options vest on the earlier of the one-year anniversary of the grant date and the date of Cingulate’s 2027 annual meeting of stockholders, and expire on 2036-07-16. Following this grant, he holds 20,000 stock options directly. The grant was not reported under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hargroves Thomas Jeffrey
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) F1 | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to Buy) — 20,000 shares (Direct)
Footnotes (1)
- F1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2027 annual meeting of stockholders.
Key Figures
Stock options granted: 20,000 options
Exercise price: $4.43 per share
Expiration date: 2036-07-16
+1 more
4 metrics
Stock options granted
20,000 options
Grant of Stock Option (right to Buy) to director on 2026-07-16
Exercise price
$4.43 per share
Conversion or exercise price of granted stock options
Expiration date
2036-07-16
Expiration date of the granted stock options
Post-grant derivative holdings
20,000 options
Total stock options held directly by Hargroves after the grant
Key Terms
Stock Option (right to Buy), exercise price, vesting, Rule 10b5-1
4 terms
Stock Option (right to Buy) financial
"security title is listed as Stock Option (right to Buy) relating to Common Stock"
exercise price financial
"The option has a conversion or exercise price of 4.4300 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests on the earlier of the one-year anniversary and the 2027 annual meeting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Rule 10b5-1 regulatory
"The grant was not reported under a Rule 10b5-1 trading plan."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Cingulate Inc. (CING) report for Thomas Jeffrey Hargroves?
Cingulate reported that director Thomas Jeffrey Hargroves received a grant of 20,000 stock options for Common Stock. The options have an exercise price of $4.43 per share, are held directly, and expire on 2036-07-16.
What is the exercise price and expiration date of the new CING stock options?
The granted stock options have an exercise price of $4.43 per share and expire on 2036-07-16. These options give the right to buy Cingulate Common Stock at that price until the stated expiration date.
How do the 20,000 Cingulate (CING) stock options granted to Hargroves vest?
The 20,000 stock options vest on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of Cingulate Inc.’s 2027 annual meeting of stockholders, creating a single vesting event tied to time or the meeting.
How many Cingulate (CING) derivative securities does Hargroves hold after this grant?
After the reported grant, Thomas Jeffrey Hargroves holds a total of 20,000 stock options directly. These options each relate to one share of Cingulate Common Stock, subject to vesting and exercisable at $4.43 per share before expiration.
Was the latest Cingulate (CING) option grant to Hargroves made under a Rule 10b5-1 plan?
No. The transaction is indicated as not made pursuant to a Rule 10b5-1 trading plan. This suggests the grant was a standard equity award rather than executed under a pre-arranged trading program for automatic transactions.